Comprehensive analysis of PPARα-dependent regulation of hepatic lipid metabolism by expression profiling

PPAR Research

Volumn , Issue , 2007, Pages

  Rakhshandehroo, Maryam ^a,b   Sanderson, Linda M ^a,b   Matilainen, Merja ^c   Stienstra, Rinke ^a,b   Carlberg, Carsten ^c   De Groot, Philip J ^a,b   Müller, Michael ^a,b   Kersten, Sander ^a,b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLGLYCEROL LIPASE; ADIPOSE TRIGLYCERIDE LIPASE; CARRIER PROTEIN; ELECTRON TRANSFERRING FLAVOPROTEIN BETA POLYPEPTIDE; ELECTRON TRANSFERRING FLAVOPROTEIN DEHYDROGENASE; ENDOTHELIAL LIPASE; HORMONE SENSITIVE LIPASE; LECITHIN TRANSFER PROTEIN; OXIDOREDUCTASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POLYPEPTIDE; THIOREDOXIN; THIOREDOXIN INTERACTING PROTEIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE CONTROL; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER CELL; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 36248982581     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2007/26839     Document Type: Article

References (45)

1. S. Kersten B. Desvergne W. Wahli walter.wahli@iba.unil.ch Roles of PPARs in health and disease. Nature 405 6785 2000 421 424
2. R. M. Evans evans@salk.edu G. D. Barish Y.-X. Wang PPARs and the complex journey to obesity. Nature Medicine 10 4 2004 355 361
3. B. Desvergne W. Wahli Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews 20 5 1999 649 688
4. V. Bocher I. Pineda-Torra J.-C. Fruchart B. Staels PPARs: transcription factors controlling lipid and lipoprotein metabolism. Annals of the New York Academy of Sciences 967 2002 7 18
5. S. A. Smith Peroxisomal proliferater-activated receptors and the regulation of lipid oxidation and adipogenesis. Biochemical Society Transactions 25 4 1997 1242 1248
6. D. Ren T. N. Collingwood E. J. Rebar A. P. Wolffe H. S. Camp PPARγ knockdown by engineered transcription factors: exogenous PPARγ2 but not PPARγ1 reactivates adipogenesis. Genes & Development 16 1 2002 27 32
7. E. D. Rosen C.-H. Hsu X. Wang C/EBPα induces adipogenesis through PPARγ: a unified pathway. Genes & Development 16 1 2002 22 26
8. E. D. Rosen B. M. Spiegelman Molecular regulation of adipogenesis. Annual Review of Cell and Developmental Biology 16 2000 145 171
9. Y.-X. Wang C.-H. Lee S. Tiep Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity. Cell 113 2 2003 159 170
10. Y.-X. Wang C.-L. Zhang R. T. Yu Regulation of muscle fiber type and running endurance by PPARδ PLoS Biology 2 10 2004 e294
11. M. D. Leibowitz mleibowitz@ligand.com C. Fiévet N. Hennuyer Activation of PPARδ alters lipid metabolism in db/db mice. FEBS Letters 473 3 2000 333 336
12. N. Di-Pö N. S. Tan L. Michalik W. Wahli B. Desvergne beatrice.desvergne@iba.unil.ch Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway. Molecular Cell 10 4 2002 721 733
13. D. Patsouris S. Mandard P. J. Voshol PPARα governs glycerol metabolism. Journal of Clinical Investigation 114 1 2004 94 103
14. P. Gervois pgervois@pharma.univ-lille2.fr R. Kleemann A. Pilon Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-α activator fenofibrate. Journal of Biological Chemistry 279 16 2004 16154 16160
15. P. Delerive J.-C. Fruchart B. Staels Peroxisome proliferator-activated receptors in inflammation control. Journal of Endocrinology 169 3 2001 453 459
16. H. Moshage A. Casini C. S. Lieber Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology 12 3, part 1 1990 511 518
17. C. L. Bevins CLBevins@ucdavis.edu The Paneth cell and the innate immune response. Current Opinion in Gastroenterology 20 6 2004 572 580
18. P. R. Devchand A. K. Hihi M. Perroud W.-D. Schleuning B. M. Spiegelman W. Wahli walter.wahli@iba.unil.ch Chemical probes that differentially modulate peroxisome proliferator-activated receptor α and BLTR, nuclear and cell surface receptors for leukotriene B 4. Journal of Biological Chemistry 274 33 1999 23341 23348
19. D. B. Allison Dallison@uab.edu X. Cui G. P. Page M. Sabripour Microarray data analysis: from disarray to consolidation and consensus. Nature Reviews Genetics 7 1 2006 55 65
20. D. D. Hong Y. Takahashi M. Kushiro T. Ide idetaka@nfri.affrc.go.jp Divergent effects of eicosapentaenoic and docosahexaenoic acid ethyl esters, and fish oil on hepatic fatty acid oxidation in the rat. Biochimica et Biophysica Acta 1635 1 2003 29 36
21. M. J. Coon mjcoon@umich.edu Cytochrome P450: nature's most versatile biological catalyst. Annual Review of Pharmacology and Toxicology 45 2005 1 25
22. X. Liu M. Milo N. D. Lawrence M. Rattray magnus@cs.man.ac.uk A tractable probabilistic model for Affymetrix probe-level analysis across multiple chips. Bioinformatics 21 18 2005 3637 3644
23. M. Dai P. Wang A. D. Boyd Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Research 33 20 2005 e175
24. S. Mandard M. Müller S. Kersten sander.kersten@wur.nl Peroxisome proliferator-activated receptor α target genes. Cellular and Molecular Life Sciences 61 4 2004 393 416
25. G. Haemmerle R. Zimmermann M. Hayn Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. Journal of Biological Chemistry 277 7 2002 4806 4815
26. R. Zimmermann J. G. Strauss G. Haemmerle Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306 5700 2004 1383 1386
27. G. Haemmerle A. Lass R. Zimmermann Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312 5774 2006 734 737
28. T. Ishida S. Choi R. K. Kundu Endothelial lipase is a major determinant of HDL level. Journal of Clinical Investigation 111 3 2003 347 355
29. W. Jin J. S. Millar U. Broedl J. M. Glick D. J. Rader rader@mail.med.upenn.edu Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo. Journal of Clinical Investigation 111 3 2003 357 362
30. U. C. Broedl C. Maugeais D. Marchadier J. M. Glick D. J. Rader rader@mail.med.upenn.edu Effects of nonlipolytic ligand function of endothelial lipase on high density lipoprotein metabolism in vivo. Journal of Biological Chemistry 278 42 2003 40688 40693
31. F. E. Frerman Acyl-CoA dehydrogenases, electron transfer flavoprotein and electron transfer flavoprotein dehydrogenase. Biochemical Society Transactions 16 3 1988 416 418
32. J. D. Beckmann F. E. Frerman Electron-transfer flavoprotein-ubiquinone oxidoreductase from pig liver: purification and molecular, redox, and catalytic properties. Biochemistry 24 15 1985 3913 3921
33. S. Kersten J. Seydoux J. M. Peters F. J. Gonzalez B. Desvergne W. Wahli walter.wahli@iba.unil.ch Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. Journal of Clinical Investigation 103 11 1999 1489 1498
34. C. M. Jenkins D. J. Mancuso W. Yan H. F. Sims B. Gibson R. W. Gross Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A 2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. Journal of Biological Chemistry 279 47 2004 48968 48975
35. T. C. Leone C. J. Weinheimer D. P. Kelly dkelly@imgate.wustl.edu A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: the PPARα-null mouse as a model of fatty acid oxidation disorders. Proceedings of the National Academy of Sciences of the United States of America 96 13 1999 7473 7478
36. T. E. Akiyama C. J. Nicol C. Fievet Peroxisome proliferator-activated receptor-α regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines. Journal of Biological Chemistry 276 42 2001 39088 39093
37. G. Svegliati-Baroni g.svegliati@univpm.it C. Candelaresi S. Saccomanno A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-α and n-3 polyunsaturated fatty acid treatment on liver injury. American Journal of Pathology 169 3 2006 846 860
38. M. M. Haluzik Z. Lacinova M. Dolinkova Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-α agonist treatment is accompanied by paradoxical increase of circulating resistin levels. Endocrinology 147 9 2006 4517 4524
39. T. Nagasawa tatsuya_nagasawa@pharm.kissei.co.jp Y. Inada S. Nakano Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet. European Journal of Pharmacology 536 1-2 2006 182 191
40. Y. Harano K. Yasui T. Toyama Fenofibrate, a peroxisome proliferator-activated receptor α agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver. Liver International 26 5 2006 613 620
41. M. G. McCoy G.-S. Sun D. Marchadier C. Maugeais J. M. Glick D. J. Rader Characterization of the lipolytic activity of endothelial lipase. Journal of Lipid Research 43 6 2002 921 929
42. M. K. Wu D. E. Cohen dcohen@partners.org Altered hepatic cholesterol metabolism compensates for disruption of phosphatidylcholine transfer protein in mice. American Journal of Physiology 289 3 2005 G456 G461
43. J. S. Bodnar A. Chatterjee L. W. Castellani Positional cloning of the combined hyperlipidemia gene Hyplip1. Nature Genetics 30 1 2002 110 116
44. K. L. Donnelly M. R. Margosian S. S. Sheth A. J. Lusis E. J. Parks eparks@umn.edu Increased lipogenesis and fatty acid reesterification contribute to hepatic triacylglycerol stores in hyperlipidemic Txnip-/- mice. Journal of Nutrition 134 6 2004 1475 1480
45. S. S. Sheth L. W. Castellani S. Chari Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition. Journal of Lipid Research 46 1 2005 123 134